跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
mAb-5
首页
药物
mAb-5
mAb-5
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Monoclonal antibodies that recognize antigens associated with tumor metastasis
申请人: UNIV NEW YORK STATE RES FOUND
优先权: 2000
US
PD-1 AND LAG-3 BINDING MOLECULES AND METHODS OF USE THEREOF
申请人: MACROGENICS INC
优先权: 2015
CN
EP
US
WO
15 件公开
Mab H2 monoclonal antibody and application thereof
申请人: WUHAN INST VIROLOGY CAS
优先权: 2026
CN
LAG-3-BINDING MOLECULKES AND METHODS OF USE THEREOF
申请人: MACROGENICS INC
优先权: 2015
CN
EP
US
WO
10 件公开
ANTI-HUMAN PD-1 ANTIBODY CRYSTALS AND METHODS OF USE THEREOF
申请人: MERCK SHARP & DOHME LLC
优先权: 2018
CN
EP
US
WO
7 件公开
Monoclonal antibody for detecting varicella-zoster virus glycoprotein E and application thereof
申请人: OLYMVAX BIOPHARMACEUTICALS INC
优先权: 2026
CN
FAST-DISSOLVING ANTIBODY TABLETS FOR MUCOSAL DELIVERY
申请人: MUCOMMUNE LLC
优先权: 2025
WO
Anti-CD19 antibodies and methods of use and preparation thereof
申请人: CHENGDU BAILIDUOTE BIOLOGICAL PHARMACEUTICAL CO LTD
优先权: 2020
CN
3 件公开
药物
反馈